References
Dai, J., Lv, J., Zhu, M., Wang, Y., Qin, N., Ma, H., He, Y.Q., Zhang, R., Tan, W., Fan, J., et al. (2019). Identification of risk loci and a polygenic risk score for lung cancer: A large-scale prospective cohort study in Chinese populations. Lancet Respir Med 7, 881–891.
Dong, J., Hu, Z., Wu, C., Guo, H., Zhou, B., Lv, J., Lu, D., Chen, K., Shi, Y., Chu, M., et al. (2012). Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. Nat Genet 44, 895–899.
Hu, Z., Wu, C., Shi, Y., Guo, H., Zhao, X., Yin, Z., Yang, L., Dai, J., Hu, L., Tan, W., et al. (2011). A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet 43, 792–796.
Hung, R.J., Warkentin, M.T., Brhane, Y., Chatterjee, N., Christiani, D.C., Landi, M.T., Caporaso, N.E., Liu, G., Johansson, M., Albanes, D., et al. (2021). Assessing lung cancer absolute risk trajectory based on a polygenic risk model. Cancer Res 81, 1607–1615.
Jin, G., Zhu, M., Yin, R., Shen, W., Liu, J., Sun, J., Wang, C., Dai, J., Ma, H., Wu, C., et al. (2015). Low-frequency coding variants at 6p21.33 and 20q11.21 are associated with lung cancer risk in Chinese populations. Am J Hum Genet 96, 832–840.
Jin, G., Ma, H., Wu, C., Dai, J., Zhang, R., Shi, Y., Lu, J., Miao, X., Wang, M., Zhou, Y., et al. (2012). Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese. Am J Hum Genet 91, 928–934.
Jin, G., Lv, J., Yang, M., Wang, M., Zhu, M., Wang, T., Yan, C., Yu, C., Ding, Y., Li, G., et al. (2020). Genetic risk, incident gastric cancer, and healthy lifestyle: A meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol 21, 1378–1386.
Qin, N., Li, Y., Wang, C., Zhu, M., Dai, J., Hong, T., Albanes, D., Lam, S., Tardon, A., Chen, C., et al. (2021). Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma. Front Med 15, 275–291.
Shao, L., Zuo, X., Yang, Y., Zhang, Y., Yang, N., Shen, B., Wang, J., Wang, X., Li, R., Jin, G., et al. (2019). The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating tnfrsf19 expression. Genome Biol 20, 19–1696.
Wang, C., Yin, R., Dai, J., Gu, Y., Cui, S., Ma, H., Zhang, Z., Huang, J., Qin, N., Jiang, T., et al. (2018). Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients. Nat Commun 9, 2054.
Rights and permissions
About this article
Cite this article
Profile of Dr. Hong-Bing Shen. Sci. China Life Sci. 65, 16–18 (2022). https://doi.org/10.1007/s11427-021-1979-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-021-1979-9